3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Rectal Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Lymphoma
2
Leukemia
2
Colonic Neoplasms
2
Xanthomatosis, Cerebrotendinous
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tetanus
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Interventions
Influenza Vaccines
3
SARS-CoV-2 inactivated vaccines
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Influenza, Human
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled